Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics

被引:8
|
作者
Yuan, Heng [1 ]
Jung, Eun-Soo [2 ,3 ,4 ]
Chae, Soo-Wan [2 ,3 ,4 ]
Jung, Su-Jin [2 ,3 ,4 ]
Daily, James W. [5 ]
Park, Sunmin [1 ,6 ]
机构
[1] Hoseo Univ, Dept Bioconvergence, Asan 31499, South Korea
[2] Jeonbuk Natl Univ Hosp, Biomed Res Inst, Clin Trial Ctr Funct Foods, Jeonju 54907, South Korea
[3] Jeonbuk Natl Univ Hosp, Biomed Res Inst, Clin Trial Ctr K FOOD Microbiome, Jeonju 54907, South Korea
[4] Jeonbuk Natl Univ, Res Inst Clin Med, Jeonju 54907, South Korea
[5] Daily Mfg Inc, Dept R&D, Rockwell, NC 28138 USA
[6] Hoseo Univ, Obes Diabet Res Ctr, Dept Food & Nutr, 20 Hoseoro79 Bungil, Asan 31499, South Korea
关键词
metabolic dysfunction-associated steatotic liver disease; HFFs; gut microbiota; omics approach; HEPATIC STEATOSIS; NONCODING RNAS; DISEASE; PATHOGENESIS; CELLS; INFLAMMATION; CROSSTALK; NAFLD; NASH;
D O I
10.3390/nu16183061
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Metabolic dysfunction-associated steatotic liver disorder (MASLD) is increasingly prevalent globally, highlighting the need for preventive strategies and early interventions. This comprehensive review explores the potential of health functional foods (HFFs) to maintain healthy liver function and prevent MASLD through an integrative analysis of network pharmacology, gut microbiota, and multi-omics approaches. We first examined the biomarkers associated with MASLD, emphasizing the complex interplay of genetic, environmental, and lifestyle factors. We then applied network pharmacology to identify food components with potential beneficial effects on liver health and metabolic function, elucidating their action mechanisms. This review identifies and evaluates strategies for halting or reversing the development of steatotic liver disease in the early stages, as well as biomarkers that can evaluate the success or failure of such strategies. The crucial role of the gut microbiota and its metabolites for MASLD prevention and metabolic homeostasis is discussed. We also cover state-of-the-art omics approaches, including transcriptomics, metabolomics, and integrated multi-omics analyses, in research on preventing MASLD. These advanced technologies provide deeper insights into physiological mechanisms and potential biomarkers for HFF development. The review concludes by proposing an integrated approach for developing HFFs targeting MASLD prevention, considering the Korean regulatory framework. We outline future research directions that bridge the gap between basic science and practical applications in health functional food development. This narrative review provides a foundation for researchers and food industry professionals interested in developing HFFs to support liver health. Emphasis is placed on maintaining metabolic balance and focusing on prevention and early-stage intervention strategies.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] HEALTH GOAL COACHING IS ASSOCIATED WITH HIGHER HEALTH GOAL MOTIVATION AND SATISFACTION IN PARTICIPANTS AT RISK FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Price, Jillian
    Gayam, Sai Greeshma
    Gutema, Diborah
    Escheik, Carey
    Weinstein, Ali
    de Avila, Leyla
    Gerber, Lynn
    Younossi, Zobair
    HEPATOLOGY, 2024, 80 : S889 - S890
  • [22] Time-trends of fibrosis and steatosis in metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective cohort analysis
    Arora, Umang
    Biswas, Sagnik
    Dwarkanathan, Vignesh
    Sheikh, Sabreena
    Agarwal, Ayush
    Aggarwal, Arnav
    Mehta, Shubham
    Shalimar, Shalimar
    JOURNAL OF HEPATOLOGY, 2024, 80 : S506 - S506
  • [23] Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
    Malik, Adnan
    Javaid, Sadia
    Malik, Muhammad Imran
    Qureshi, Shahbaz
    ANNALS OF HEPATOLOGY, 2024, 29 (06)
  • [24] Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD)
    Lan, Yuanfeng
    Song, Ran
    Feng, Duiping
    He, Junqi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [25] Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis
    Zu, Xianpeng
    Xin, Jiayun
    Xie, Haisheng
    Xu, Xike
    Shen, Yunheng
    Wang, Jinxin
    Tian, Saisai
    Wen, Yukun
    Li, Hongxia
    Yang, Jishun
    Fang, Yiqun
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 344 : 563 - 576
  • [26] Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
    Abdelhameed, Farah
    Kite, Chris
    Lagojda, Lukasz
    Dallaway, Alexander
    Chatha, Kamaljit Kaur
    Chaggar, Surinderjeet S.
    Dalamaga, Maria
    Kassi, Eva
    Kyrou, Ioannis
    Randeva, Harpal S.
    CURRENT OBESITY REPORTS, 2024, 13 (03): : 510 - 531
  • [27] MULTI-ANCESTRY WHOLE GENOME SEQUENCING (WGS) AND META-ANALYSIS TO IDENTIFY LOCI ASSOCIATED WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Raut, Chinmay
    Chen, Yanhua
    Oliveri, Antonino
    Feitosa, Mary F.
    O'Connell, Jeffrey R.
    Ryan, Kathleen A.
    Rotter, Jerome I.
    Rich, Stephen S.
    Young, Kendra A.
    Hakim, Aaron
    Peyser, Patricia A.
    Bielak, Lawrence F.
    Long, Michelle T.
    Liu, Ching-Ti
    Speliotes, Elizabeth K.
    Palmer, Nicholette D.
    HEPATOLOGY, 2023, 78 : S199 - S199
  • [28] The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
    Li, Xiaoyan
    He, Jie
    Sun, Qiuhua
    CLINICAL NUTRITION, 2024, 43 (09) : 2005 - 2016
  • [29] The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis
    Lv, Qiong
    Zhao, Huashan
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [30] Bariatric Surgery Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: Propensity Matched Analysis of a Large Multi-institutional Cohort
    Iqbal, Amna
    Rasheed, Waqas
    Ali, Hassam
    Hayat, Umar
    Patel, Rayna
    Khan, Aqsa
    Ahmed, Zohaib
    Moond, Vishali
    Dahiya, Dushyant S.
    Ahuja, Priyanka
    Awan, Rehmat Ullah
    Singh, Shailendra
    Nawras, Ali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1406 - S1407